The proliferative activity of B16.F10 melanoma cells co-cultured with M2 macrophages which were previously treated for 24 h with IL-13-LCL-SIM, LCL-SIM, and LCL devoid of drug (control) was assessed as in Figure 2A. This evidence concerns the gene IL13 and melanoma.